Protalix BioTherapeutics, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -821.39%103.30%17.21%75.37%82.12%83.27%8.71%19.03%72.83%80.08%82.71%57.37%58.87%64.91%54.46%
EBT Margin -8,239.57%-451.16%-435.62%-34.91%3,298.40%-950.72%-627.98%-406.08%-209.90%-78.83%-34.16%-10.37%-71.92%-30.22%13.08%7.78%
EBIT Margin -8,239.43%-451.16%-435.62%-34.91%3,198.40%-810.64%-542.39%-360.51%-163.76%-56.39%-19.59%4.31%-53.36%-27.32%15.97%7.34%
EBITDA Margin -8,239.43%-451.16%-435.62%-34.91%3,198.40%-810.64%-542.39%-360.51%-163.76%-56.39%-19.59%4.31%-53.36%-27.32%15.97%7.34%
Operating Margin -8,239.43%-451.16%-435.62%-34.91%3,198.40%-810.64%-542.39%-360.51%-163.76%-56.39%-19.59%4.31%-53.36%-27.32%15.97%7.34%
Net Margin -8,239.57%-451.16%-435.62%-34.91%-652.30%95.23%1,955.06%-2.05%-209.90%-78.83%-34.16%-10.37%-71.92%-31.33%7.97%5.49%
FCF Margin 9,860.05%-697.37%-349.09%-4.11%3,055.68%-853.42%-601.15%-358.16%-52.02%-24.61%-36.54%-42.55%-30.62%-53.80%-3.77%13.84%
Efficiency
Inventory Average 0.73M2.16M6.00M5.70M4.61M5.51M6.54M8.20M8.36M10.62M15.52M17.38M17.92M20.14M
Assets Average 74.74M81.70M58.27M65.27M96.03M95.84M87.81M89.75M77.23M66.67M53.26M56.66M70.80M64.73M70.11M78.93M
Equity Average 30.11M2.28M-18.70M-14.72M-15.15M-41.27M-22.36M0.46M-19.71M-41.17M-61.60M-48.68M-16.54M-8.34M11.46M38.39M
Invested Capital 15.88M-11.32M-26.08M-3.36M-26.95M-55.60M10.87M43.91M-23.54M-52.88M-70.32M27.39M-6.04M-10.64M53.82M43.21M
Asset Utilization Ratio 0.010.080.140.53-0.010.040.050.100.270.511.031.110.540.740.930.68
Leverage & Solvency
Interest Coverage Ratio -31.98-5.79-6.34-7.91-3.55-2.51-1.350.28-2.72-5.153.293.69
Debt to Equity -0.25-1.62-0.090.40-5.84-0.20-2.010.60
Debt Ratio 0.130.070.020.040.710.080.800.24
Equity Ratio 0.16-0.17-0.50-0.04-0.24-0.710.11-0.12-0.41-0.87-1.55-0.40-0.08-0.190.400.59
Times Interest Earned -31.98-5.79-6.34-7.91-3.55-2.51-1.350.28-2.72-5.153.293.69
Valuation
Enterprise Value 430.23M774.59M395.12M433.05M277.56M117.59M25.42M-18.81M41.22M8.34M30.88M82.47M10.11M47.23M85.29M103.60M
Market Capitalization 511.50M810.49M422.12M485.08M363.96M172.36M101.80M44.47M92.39M46.14M48.67M121.01M49.10M69.41M129.85M138.43M
Return Ratios
Return on Sales -82.40%-4.51%-4.36%-0.35%-6.52%0.95%19.55%-0.02%-2.10%-0.79%-0.34%-0.10%-0.72%-0.31%0.08%0.05%
Return on Capital Employed -0.60%-0.48%-0.92%-0.31%-0.49%-0.91%-0.31%-1.41%-0.63%-0.47%-0.82%-0.09%-0.54%-0.40%0.43%0.07%
Return on Invested Capital 0.30%0.06%
Return on Assets -0.43%-0.37%-0.63%-0.19%0.07%0.04%0.97%0.00%-0.57%-0.40%-0.35%-0.12%-0.39%-0.23%0.07%0.04%
Return on Equity -1.06%-13.14%1.95%0.83%-0.46%-0.08%-3.82%-0.41%2.24%0.66%0.30%0.13%1.67%1.79%0.46%0.08%